SureTrader SureTrader
Home > Boards > US OTC > Medical - Healthcare >

Great Basin Scientific Inc. (GBSN)

GBSN RSS Feed
Add GBSN Price Alert      Hide Sticky   Hide Intro
Moderator: Atlanta1, TKane
Search This Board:
Last Post: 12/6/2016 2:21:50 PM - Followers: 314 - Board type: Free - Posts Today: 10




NASDAQ : $GBSN

Great Basin – Corporate Headquarters

2441 SOUTH 3850 WEST, SALT LAKE CITY, UT, 84210
PHONE : 801-990-1055
TOLL FREE : 888-360-4022
SUPPORT : 888-333-9793


ICR Media:
Kate Ottavio Kent, 203-682-8276
Kate.Ottavio-Kent@icrinc.com
or
Investor Relations:
Bob Yedid, 646-277-1250
bob.yedid@icrinc.com
 
 http://www.gbscience.com/

FACEBOOK PAGE : https://www.facebook.com/gbscience

CEO : RYAN ASHTON
 


 
 
Great Basin Scientific is a molecular diagnostics company that commercializes breakthrough chip-based technologies.
The Company is dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases.
The Great Basin molecular diagnostics system is uniquely capable of answering both the ‘What is it?’ question—answered by a low-cost, low-plex assay—and the
‘What is causing it?’ question, identified by a multi-plex panel. The Company has FDA Clearance on tests for 
Clostridium difficile and Group B streptococcus.
Low-plex tests in development include SA Nasal and Staph ID/R and multi-plex panels being developed include Fungal Pathogens, Shiga toxin-producing E. coli (STEC) and
Food-borne Pathogens (GI Panel). The Company’s vision is to make molecular diagnostic testing so simple and cost-effective that every patient will be tested for every
serious infection, reducing misdiagnoses and significantly limiting the spread of infectious disease. Fast, accurate results. More answers. One easy-to-use and cost-effective system.
Only Great Basin is delivering a powerful product pipeline of tests and panels that allows every lab to adopt molecular diagnostics that will assist clinicians in better
diagnosing and managing patients outcomes. The company sells its diagnostic tests through a direct sales force in the United States, as well as through
distributors in the European Union and New Zealand. Great Basin Scientific, Inc. is headquartered in Salt Lake City, Utah.
 


PATENTS
US8936921: METHODS OF ISOTHERMAL APPLICATION USING BLOCKED PRIMERS 
US8637250 : SYSTEMS & METHODS OF POINT-OF-CARE AMPLIFICATION & DETECTION OF POLYNUCLEOTIDES
US20130331298: ANALYZER & DISPOSAL CARTRIDGE FOR MOLECULAR INVITRO DIAGNOSTICS




 


 

SEC FILINGS : http://www.nasdaq.com/symbol/gbsn/sec-filings



RODMAN & RENSHAW SEPTEMBER 2015 CONFERENCE : http://www.webcaster4.com/Player/Index?webcastId=10343&uid=2110463&g=f8257b32-4e1d-4735-a3d5-9febfb8d4ea0&sid=


PRIMARY COMPETITOR : MERIDIAN BIOSCIENCE
http://www.meridianbioscience.com/diagnostic-products/c-difficile/illumigene-molecular-diagnostic-system/illumigene-c-difficile.aspx


 
SHARE STRUCTURE BY DATE & STATUS OF WARRANTS & CONVERTIBLE PREFERREDS
DATE FLOAT OUTSTANDING AUTHORIZED Series C WARRANTS Series E CONVERTIBLE PREFERREDS
9/1/2015   26,998,860   18.643,040 2,181,250
9/3/2015   37,600,618   18,011,700 680,725
9/9/2015   55,101,310   16,725,323 507,778
9/14/2015   68,939,734   16,084,583 144,111
9/17/2015   88,331,396   15,365,663 144,011
9/21/2015   190,630,634   12,812,555 116,711
           
           
           

 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GBSN
Current Price
Volume:
Bid Ask Day's Range
SureTrader
GBSN News: Proxy Statement (definitive) (def 14a) 12/05/2016 05:29:22 PM
GBSN News: Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) 12/05/2016 06:03:26 AM
GBSN News: Current Report Filing (8-k) 12/02/2016 05:00:42 PM
GBSN News: Securities Registration Statement (s-1/a) 12/02/2016 03:17:40 PM
GBSN News: Current Report Filing (8-k) 12/02/2016 03:17:14 PM
News News Alert: Great Basin’s Sandra Nielsen Named a 2016 Woman Worth Watching by Profiles in Diversity Journal 12/06/2016 07:30:00 AM
PostSubject
#25224   Been awhile since more GREEN VOLUME than red $GBSN... Drugdoctor 12/06/16 02:21:50 PM
#25223   Here is current LEVEL II screenshot - As Drugdoctor 12/06/16 12:32:46 PM
#25222   And my BIDS just got jumped grrrrrrr Drugdoctor 12/06/16 12:27:01 PM
#25221   Well, I'm still bidding and buying here in Drugdoctor 12/06/16 12:25:23 PM
#25220   Not me. I'm terrified of Gibby. rachelsdaddy 12/06/16 12:19:08 PM
#25219   I see LEVEL II has turned for $GBSN Drugdoctor 12/06/16 11:52:32 AM
#25218   Hmmm - Looks like you may be right! Drugdoctor 12/06/16 11:19:52 AM
#25217   I remember Gibby well. I was here during rachelsdaddy 12/06/16 09:19:19 AM
#25216   Shareholder's meeting move to Dec 22 Matt74 12/06/16 08:33:55 AM
#25215   You have got to be kidding me Jiminy Cricket 12/06/16 08:26:53 AM
#25214   dont you mean .00625 shes done chris12 12/05/16 09:11:12 AM
#25213   Target .0625 this week! Matt74 12/05/16 08:13:48 AM
#25212   if there is a bump here it will colmar 12/05/16 08:02:14 AM
#25211   1 for 300 REVERSE SPLIT - NEXT WEEK Drugdoctor 12/05/16 07:55:28 AM
#25210   All shares issued per 5pm 8k SEC filing Matt74 12/05/16 07:19:18 AM
#25209   greatest bs otc company seen since a long upanddown66 12/05/16 01:10:34 AM
#25205   re"I cannot understand while the preferred shares would Drugdoctor 12/03/16 08:53:05 AM
#25204   Colmar - you will see. Been doing this Matt74 12/03/16 08:53:03 AM
#25203   I'd hang myself at 1.27 - .0127 Cheers! Matt74 12/03/16 08:51:37 AM
#25202   BTW Holding 1.25 million avg 1.27 Matt74 12/03/16 08:50:50 AM
#25201   A 400% run fueled by naked shorts? colmar 12/03/16 08:49:42 AM
#25199   400% run in 7 trading days begins... Matt74 12/03/16 08:43:29 AM
#25196   Your insight on GBSN has been to the Rascal1 12/03/16 08:39:28 AM
#25195   Ah, but the flaw in the logic there Drugdoctor 12/03/16 08:19:51 AM
#25194   P-A-T-H-E-T-I-C SECURITY-OWNERSHIP-OF-CERTAIN-BENEFICIAL-OWNERS-AND- MANAGEMENT Drugdoctor 12/03/16 08:08:17 AM
#25193   I agree this company has be mismanaged, but Rascal1 12/03/16 08:02:51 AM
#25192   The REVERSE SPLIT is a "done deal" is Drugdoctor 12/03/16 07:55:38 AM
#25191   Vote how u want - this next split colmar 12/03/16 07:27:42 AM
#25190   Bankruptcy is always an option, but a no Rascal1 12/03/16 07:11:29 AM
#25189   The company makes it's money by selling shares... Drugdoctor 12/02/16 08:25:38 PM
#25188   Why would anyone vote yes for stocksplit/increase shares Rascal1 12/02/16 05:14:20 PM
#25185   This thing is finished. colmar 12/02/16 03:25:25 PM
#25184   selling is not over. 11mm shares, at least, colmar 12/02/16 01:38:12 PM
#25183   I'm thinking we hit .10-.15 breynolds 12/02/16 12:23:47 PM
#25182   My short term target is .0625 +400% from here Matt74 12/02/16 07:50:40 AM
#25181   8k should be released after market today Matt74 12/02/16 07:47:30 AM
#25180   300 for 1 REVERSE SPLIT and 1.5 BILLION Drugdoctor 12/02/16 05:41:53 AM
#25179   GBSN shareholders? LMAO!! You would have to have wickerman 12/02/16 04:15:46 AM
#25178   So the best time to sell this stock Switchtrade 12/01/16 11:54:38 PM
#25177   Please, someone tell me to run far, far rachelsdaddy 12/01/16 06:34:05 PM
#25176   no doubt, but there could be some good Atlanta1 12/01/16 06:01:06 PM
#25175   Don't worry, the preferred shares will carry the Drugdoctor 12/01/16 05:52:03 PM
#25174   they haven't had the vote yet. calm down. Atlanta1 12/01/16 05:50:53 PM
#25173   Time to run away - REVERSE SPLIT SEC Drugdoctor 12/01/16 05:48:06 PM
#25172   CDEL just moved to .024 time to run breynolds 12/01/16 02:56:04 PM
#25171   heads up for pretty heavy dumping this afternoon colmar 12/01/16 02:11:50 PM
#25170   I don't believe they are done selling,fairly soon colmar 12/01/16 11:34:29 AM
#25169   8k most likely out tomorrow Matt74 12/01/16 09:37:45 AM
#25168   When this runs 300% in the next 10 days Matt74 12/01/16 08:20:26 AM
#25167   Prospectus INVESTING in our stock..LOL..what a bunch of idiots..INVESTING! Faustilius 12/01/16 07:54:53 AM
PostSubject